Related Experiment Video

Updated: May 23, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Bevacizumab and breast cancer: what does the future hold?

Christina E Stevenson1, Masayuki Nagahashi, Subramaniam Ramachandran

  • 1Department of Surgery, University of Connecticut Health Center, Farmington, CT 06030, USA.

Future Oncology (London, England)
|April 21, 2012
PubMed

Insights

Bevacizumab (Avastin) targets angiogenesis in breast cancer, improving progression-free survival but not overall survival. Future therapies may target angiogenesis and lymphangiogenesis for better outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Medical Therapeutics

Background:

  • Breast cancer remains a significant health concern, with metastatic disease causing mortality despite current treatments.
  • Angiogenesis, the formation of new blood vessels, is a critical process in tumor growth and metastasis.
  • Bevacizumab, an antibody targeting VEGF-A, has been investigated as an anti-angiogenic therapy for breast cancer.

Purpose of the Study:

  • To review published clinical trials of bevacizumab in breast cancer treatment.
  • To discuss in vitro and in vivo methods for measuring angiogenesis.
  • To explore lymphangiogenesis as a potential therapeutic target in breast cancer.

Main Methods:

  • Systematic review of clinical trials involving bevacizumab for breast cancer.
  • Description of experimental techniques for assessing angiogenesis.
  • Review of literature on lymphangiogenesis in cancer progression.

Main Results:

  • Bevacizumab has demonstrated increased progression-free survival in breast cancer patients.
  • Overall survival benefits have not been consistently observed with bevacizumab treatment.
  • Angiogenesis and lymphangiogenesis are key processes in breast cancer metastasis.

Conclusions:

  • While bevacizumab shows promise in improving progression-free survival, its impact on overall survival requires further investigation.
  • Understanding and targeting angiogenesis and lymphangiogenesis are crucial for developing more effective breast cancer therapies.
  • Further research into novel therapeutic strategies targeting these vascularization processes may improve patient outcomes.

More Related Videos

Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring08:45

Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring

Published on: November 13, 2012

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...